General MedicationsORALGeneric

BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Standard Dose

20MG;25MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 078794 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 20MG;25MG Sponsor APOTEX Submission history Latest submission status date: 2024-08-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 078794 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 20MG;25MG Sponsor APOTEX Submission history Latest submission status date: 2024-08-22 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.